Testing & Quality
A peptide lab report may include chromatograms, mass spectra, purity percentages, and assay results. Here’s what those measurements actually tell you—and why they should not be treated as interchangeable.
The Amino Report Editors
PUBLISHED
UPDATED
8 min read
A peptide laboratory report can appear deceptively simple. A chromatogram, a purity percentage, a molecular-weight result, and an assay value may all appear on the same page.
But these measurements are not interchangeable.
Each analytical technique is designed to answer a different question about the sample. One method may provide information about chromatographic purity, another may help establish molecular identity, and another may measure the quantity of peptide present.
Understanding those distinctions is essential when interpreting analytical results.
A more useful approach is to ask three separate questions:
How pure is the detected material?
Is the material consistent with the compound it is claimed to be?
How much peptide is actually present in the sample?
HPLC, mass spectrometry, and quantitative assay methods can provide different pieces of that analytical picture.
High-performance liquid chromatography, or HPLC, separates components in a sample based on how they interact with the chromatographic system.
As those components pass through the instrument, they produce signals that appear as peaks on a chromatogram.
For peptide analysis, the largest peak may represent the primary peptide component, while smaller peaks can represent impurities, degradation products, or other detectable substances.
The relative area of those peaks can be used to calculate chromatographic purity.
For example, a reported result of 99.3% HPLC purity generally means that approximately 99.3% of the integrated chromatographic signal under the specified conditions was attributed to the primary peak.
That can be useful information—but it does not answer every analytical question.
HPLC purity alone does not establish molecular identity, and it does not necessarily tell you how many milligrams of peptide are present in the vial.
Those questions require additional analytical information.
A chromatogram provides a visual record of the signals detected during a chromatographic analysis.
The position of each peak is associated with its retention time, while the size or integrated area of the peak reflects its relative contribution to the detected signal.
A chromatogram can therefore provide useful information about the relative composition of a sample and reveal additional detectable peaks that may represent impurities or related substances.
But a clean-looking chromatogram should not automatically be interpreted as proof of compound identity.
Two different substances can potentially produce chromatographic signals under a given set of conditions, and retention time alone may not provide sufficient evidence to establish molecular identity.
That is why chromatographic results are often interpreted alongside another analytical technique.
For peptides, one of the most important complementary techniques is mass spectrometry.
Mass spectrometry, or MS, provides information about the molecular characteristics of a compound by measuring ions according to their mass-to-charge ratio.
For peptide analysis, this can provide evidence that the material being tested has a molecular mass consistent with the expected peptide.
More advanced mass-spectrometry techniques can also provide additional structural or sequence-related information.
This makes mass spectrometry particularly valuable for evaluating identity.
A sample may produce a very high HPLC purity result, but that does not by itself establish that the primary chromatographic peak is actually the peptide named on the label.
Mass-spectrometry data can provide an independent line of evidence addressing that question.
However, mass spectrometry answers a different question from chromatographic purity.
Evidence that a compound has the expected molecular characteristics does not, by itself, establish its purity or how much peptide is present in the sample.
An assay is intended to answer another important question: how much of the target substance is actually present?
This is different from chromatographic purity.
Imagine a hypothetical sample that produces a chromatogram showing 99.5% purity. That result indicates that the primary chromatographic component accounts for approximately 99.5% of the relevant detected signal under that method.
It does not automatically establish that a vial labeled as containing 10 mg actually contains 10 mg of peptide.
A quantitative assay or content determination is designed to address the amount of peptide present, using an analytical method appropriate for that purpose.
This distinction is why purity and peptide content should not be treated as interchangeable numbers.
A sample can have very high chromatographic purity while the measured peptide content differs from the nominal amount stated for the sample.
It can be helpful to think of peptide analysis as answering three separate questions.
Purity: How much of the detected chromatographic signal is associated with the primary component relative to other detected components?
Identity: Is the material consistent with the peptide it is claimed to be?
Content: How much of the target peptide is actually present in the sample?
These questions are related, but none automatically answers the others.
A strong HPLC result does not eliminate the need for identity testing. A molecular-mass result consistent with the expected peptide does not establish chromatographic purity. And neither measurement necessarily confirms the quantity of peptide present.
This is why a laboratory report containing multiple complementary analytical results can provide a much more informative picture than a single “99%+ purity” value.
The goal is not to collect the largest number of tests possible. It is to use appropriate analytical methods to answer the specific questions being asked about the sample.
The real value of analytical testing becomes clearer when different methods are interpreted together rather than in isolation.
Consider a hypothetical peptide sample with the following results:
HPLC purity: 99.4%
Mass spectrometry: Observed molecular mass consistent with the expected peptide
Assay / peptide content: 9.7 mg
If the sample were nominally labeled as containing 10 mg, each result would tell us something different.
The HPLC result provides information about chromatographic purity.
The mass-spectrometry result provides evidence supporting molecular identity.
The assay provides information about the quantity of peptide measured in the sample.
None of those results makes the others unnecessary.
Together, however, they provide a much more informative analytical picture than simply stating:
“99.4% pure.”
This is why understanding the purpose of each test matters just as much as reading the number printed beside it.
A stronger analytical package does not rely on one impressive percentage or one instrument result.
Instead, it uses complementary methods to evaluate different characteristics of the sample.
Depending on the purpose of the analysis, useful documentation may include:
HPLC or UHPLC data to evaluate chromatographic purity and related substances.
Mass-spectrometry data to provide evidence supporting molecular identity.
Quantitative assay or content testing to determine how much target peptide is present.
Clearly identified sample and batch information connecting the analytical results to the material tested.
Test dates, methods, and laboratory information providing traceability for the analysis.
Supporting chromatograms, spectra, or other analytical data allowing the reported summary results to be viewed in context.
Importantly, even this type of analytical package should not be interpreted as answering questions that were never tested.
For example, chemical purity and identity testing do not automatically establish microbiological attributes such as sterility or endotoxin levels. Those require separate testing designed specifically for those purposes.
The strength of an analytical report therefore depends not simply on how much information it contains, but on whether the methods actually address the claims being made about the sample.
A peptide laboratory report should not be reduced to a single purity percentage.
HPLC, mass spectrometry, and quantitative assay testing answer different analytical questions, and understanding those differences makes the results considerably more meaningful.
HPLC can provide information about chromatographic purity. Mass spectrometry can provide evidence supporting molecular identity. Quantitative testing can help determine how much peptide is actually present.
When these results are evaluated together—and connected to a clearly identified sample, batch, analytical method, and laboratory—they provide a much more complete picture of the material being characterized.
The most useful question when reading a peptide lab report is therefore not:
“What's the purity?”
It is:
“What was actually tested, what did each test measure, and what do the combined results allow us to conclude?”
SOURCES / REFERENCES
Key sources include FDA/ICH analytical guidance and peer-reviewed literature on peptide chromatography, mass spectrometry, purity, identity, and quantitative characterization.
International Council for Harmonisation (ICH). Q2(R2) Validation of Analytical Procedures. 2024.
Prabhala BK, Mirza O, Højrup P, Hansen PR. Characterization of Synthetic Peptides by Mass Spectrometry. Methods in Molecular Biology. 2015;1348:77–82. DOI: 10.1007/978-1-4939-2999-3_9.
Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. Journal of the American Society for Mass Spectrometry. 2021;32(8):1852–1860. DOI: 10.1021/jasms.0c00479.
Li M, Josephs RD, Daireaux A, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 2018;410:5059–5070. DOI: 10.1007/s00216-018-1155-y.
Wang C, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. AAPS Journal. 2023.
CONTINUE READING
Testing & Quality
A peptide labeled “99% pure” may sound nearly perfect. But that number answers a narrower analytical question than many people realize. Here’s what peptide purity can tell us—and what it cannot.
Testing & Quality
A Certificate of Analysis can look authoritative at a glance. But what information actually makes a COA useful—and what can a single document really establish about a peptide sample?
Compound Research
Retatrutide is an investigational triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. This review examines its mechanism, published clinical research, emerging Phase 3 findings, and the questions that remain unanswered.
